News

Metabolic monitoring suboptimal for dementia patients taking antipsychotics

Publish date: April 14, 2015

 

AT THE AAGP ANNUAL MEETING

References

Dr. Mittal had no financial disclosures.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Pages

Recommended Reading

Drugs approved in 2013
MDedge Neurology
Million Hearts indicators coming up short
MDedge Neurology
Poor cardiovascular health predicted cognitive impairment
MDedge Neurology
VIDEO: Teen brain reacts to sugar differently
MDedge Neurology
Pushing LDL below 25 mg/dL with alirocumab safe ‘so far’
MDedge Neurology
FDA approves vagal blocking device for obesity
MDedge Neurology
Broad application of JNC-8 would save lives, reduce costs
MDedge Neurology
Headway being made in developing biomarkers for PTSD
MDedge Neurology
Anticipation runs high for coming megatrials in general cardiology
MDedge Neurology
Updated IMPROVE-IT results show bigger benefits
MDedge Neurology